Pravardhan Rajashekar Birthi, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 403 Lexington Cir, Grand Island, NE 68803 Phone: 308-675-3222 Fax: 308-675-3234 |
Kelsey N Wergin, PA-C Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 7121 Stephanie Ln Ste 102, Lincoln, NE 68516 Phone: 402-413-5010 |
Dr. Thomas Andre Brooks, M.D. Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 4242 Farnam St, Suite 550, Omaha, NE 68131 Phone: 402-559-8600 Fax: 402-559-5010 |
Dr. Kevin Scott Balter, MD Pain Medicine - Interventional Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 825 N 90th St, Omaha, NE 68114 Phone: 402-391-7246 Fax: 402-391-1302 |
Dr. Richard G. Belatti Jr., M.D. Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 7837 Chicago Plz, Omaha, NE 68114 Phone: 402-390-6226 Fax: 402-390-6220 |
Dr. Patricia J Chudomelka, M.D. Pain Medicine - Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 11819 Miracle Hills Dr, Suite 105, Omaha, NE 68154 Phone: 402-978-5156 Fax: 402-341-3616 |
David Lojero, MD Pain Medicine - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 11111 S 84th St, Papillion, NE 68046 Phone: 402-717-4866 |
News Archive
The Council for Disability Awareness (CDA) is alerting all employers that disabling illnesses have become one of the fastest growing threats to employees' income. In fact, they now account for 55 percent of workplace absences.
Nanomaterials are poised for widespread use in the construction industry, where they can offer significant advantages for a variety of applications ranging from making more durable concrete to self-cleaning windows. But widespread use in building materials comes with potential environmental and health risks when those materials are thrown away. Those are the conclusions of a new study published by Rice University engineering researchers this month in ACS Nano.
An international team of researchers has discovered a way to identify, at a molecular level, malaria-causing Plasmodium falciparum parasites that are resistant to artemisinin, the key drug for treating this disease.
That's the finding of chemists at Ohio State University, who have successfully tested such molecules against portions of HIV and Hepatitis C virus RNA in the laboratory. They've also created molecules that act like ACE, or angiotensin-converting enzyme, inhibitors - drugs that are used to lower blood pressure.
› Verified 4 days ago